Medpace Holdings, Inc. (MEDP)

USD 305.11

(0.95%)

Long Term Debt Summary of Medpace Holdings, Inc.

  • Medpace Holdings, Inc.'s latest annual long term debt in 2023 was 142.12 Million USD , up 2.34% from previous year.
  • Medpace Holdings, Inc.'s latest quarterly long term debt in 2024 Q2 was 131.79 Million USD , down 0.0% from previous quarter.
  • Medpace Holdings, Inc. reported annual long term debt of 138.86 Million USD in 2022, up 6.03% from previous year.
  • Medpace Holdings, Inc. reported annual long term debt of 130.96 Million USD in 2021, up 13.74% from previous year.
  • Medpace Holdings, Inc. reported quarterly long term debt of 131.79 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Medpace Holdings, Inc. reported quarterly long term debt of 136.15 Million USD for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Medpace Holdings, Inc. (2023 - 2014)

Historical Annual Long Term Debt of Medpace Holdings, Inc. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 142.12 Million USD 2.34%
2022 138.86 Million USD 6.03%
2021 130.96 Million USD 13.74%
2020 115.14 Million USD 154.67%
2019 45.21 Million USD -43.29%
2018 79.72 Million USD -61.13%
2017 205.11 Million USD 35.6%
2016 151.26 Million USD -59.97%
2015 377.88 Million USD -23.12%
2014 491.51 Million USD 0.0%

Peer Long Term Debt Comparison of Medpace Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -4523.357%
Applied DNA Sciences, Inc. 739.16 Thousand USD -19127.449%
Aspira Women's Health Inc. 1.43 Million USD -9838.601%
Biodesix, Inc. 35.22 Million USD -303.469%
BioNexus Gene Lab Corp. 98.76 Thousand USD -143802.069%
bioAffinity Technologies, Inc. 1.11 Million USD -12606.845%
bioAffinity Technologies, Inc. 1.11 Million USD -12606.845%
Bionano Genomics, Inc. 7.17 Million USD -1880.794%
CareDx, Inc 28.27 Million USD -402.589%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD -901.0%
DarioHealth Corp. 24.59 Million USD -477.943%
Exact Sciences Corporation 2.47 Billion USD 94.258%
Fulgent Genetics, Inc. 10.11 Million USD -1305.618%
Guardant Health, Inc. 1.13 Billion USD 87.533%
ICON Public Limited Company 3.66 Billion USD 96.123%
IDEXX Laboratories, Inc. 622.88 Million USD 77.183%
Illumina, Inc. 1.48 Billion USD 90.455%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -174660.218%
iSpecimen Inc. 29.13 Thousand USD -487788.774%
Standard BioTools Inc. 3.98 Million USD -3468.215%
MDxHealth SA 35.56 Million USD -299.623%
23andMe Holding Co. 67.84 Million USD -109.48%
Myriad Genetics, Inc. 130.9 Million USD -8.573%
Mainz Biomed B.V. 2.19 Million USD -6372.185%
ENDRA Life Sciences Inc. 192.06 Thousand USD -73897.98%
NeoGenomics, Inc. 606.06 Million USD 76.55%
Neogen Corporation 888.39 Million USD 84.002%
Inotiv, Inc. 399.4 Million USD 64.417%
Natera, Inc. 282.94 Million USD 49.77%
OPKO Health, Inc. 222.03 Million USD 35.991%
Psychemedics Corporation 945 Thousand USD -14939.365%
Prenetics Global Limited 867.21 Thousand USD -16288.324%
Prenetics Global Limited 867.21 Thousand USD -16288.324%
Precipio, Inc. 106 Thousand USD -133977.358%
Personalis, Inc. 1.23 Million USD -11417.18%
RadNet, Inc. 812.06 Million USD 82.499%
Sera Prognostics, Inc. 840 Thousand USD -16819.286%
Sotera Health Company 2.22 Billion USD 93.609%
Neuronetics, Inc. 59.28 Million USD -139.735%
Star Equity Holdings, Inc. 1.14 Million USD -12312.402%
Star Equity Holdings, Inc. 1.14 Million USD -12312.402%
Trinity Biotech plc 54.65 Million USD -160.054%
Twist Bioscience Corporation 79.17 Million USD -79.508%
Exagen Inc. 19.23 Million USD -639.026%